Pfizer and the $200 Billion-Dollar Cardiovascular Market
- Posted on July 23, 2026
- By International Business Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
Pfizer and the $200 Billion-Dollar Cardiovascular Market
Pfizer's cardiovascular business highlights the intersection of drug pricing, marketing, patents, and competition in the rapidly growing $200 billion heart disease market.